The global veterinary medicine market size accounted for USD 52.76 billion in 2024, grew to USD 56.68 billion in 2025 and is predicted to surpass around USD 108.03billion by 2034, representing a healthy CAGR of 7.43% between 2024 and 2034. The North America Veterinary Medicine Market size is calculated at USD 16.88 billion in 2024 and is expected to grow at a fastest CAGR of 7.58% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Veterinary Medicine Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Veterinary Medicine Market, by Animal Type, 2024-2034
8.1.1. Production
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Companion
8.1.2.1. Market Revenue and Forecast (2021-2034)
9.1. Veterinary Medicine Market, by Product, 2024-2034
9.1.1. Biologics
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Others
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Pharmaceuticals
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Medicated Feed Additives
9.1.4.1. Market Revenue and Forecast (2021-2034)
10.1. Veterinary Medicine Market, by Mode of Delivery, 2024-2034
10.1.1. Oral
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Parenteral
10.1.2.1. Market Revenue and Forecast (2021-2034)
11.1. Veterinary Medicine Market, by End-User, 2024-2034
11.1.1. Reference Laboratories
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Point-of-care Testing/In-house Testing
11.1.2.1. Market Revenue and Forecast (2021-2034)
11.1.3. Veterinary Hospitals & Clinics
11.1.3.1. Market Revenue and Forecast (2021-2034)
11.1.4. Others
11.1.4.1. Market Revenue and Forecast (2021-2034)
12.1. North America
12.1.1. Market Revenue and Forecast, by Animal Type (2021-2034)
12.1.2. Market Revenue and Forecast, by Product (2021-2034)
12.1.3. Market Revenue and Forecast, by Mode of Delivery (2021-2034)
12.1.4. Market Revenue and Forecast, by End-User (2021-2034)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Animal Type (2021-2034)
12.1.5.2. Market Revenue and Forecast, by Product (2021-2034)
12.1.5.3. Market Revenue and Forecast, by Mode of Delivery (2021-2034)
12.1.5.4. Market Revenue and Forecast, by End-User (2021-2034)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Animal Type (2021-2034)
12.1.6.2. Market Revenue and Forecast, by Product (2021-2034)
12.1.6.3. Market Revenue and Forecast, by Mode of Delivery (2021-2034)
12.1.6.4. Market Revenue and Forecast, by End-User (2021-2034)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Animal Type (2021-2034)
12.2.2. Market Revenue and Forecast, by Product (2021-2034)
12.2.3. Market Revenue and Forecast, by Mode of Delivery (2021-2034)
12.2.4. Market Revenue and Forecast, by End-User (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Animal Type (2021-2034)
12.2.5.2. Market Revenue and Forecast, by Product (2021-2034)
12.2.5.3. Market Revenue and Forecast, by Mode of Delivery (2021-2034)
12.2.5.4. Market Revenue and Forecast, by End-User (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Animal Type (2021-2034)
12.2.6.2. Market Revenue and Forecast, by Product (2021-2034)
12.2.6.3. Market Revenue and Forecast, by Mode of Delivery (2021-2034)
12.2.6.4. Market Revenue and Forecast, by End-User (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Animal Type (2021-2034)
12.2.7.2. Market Revenue and Forecast, by Product (2021-2034)
12.2.7.3. Market Revenue and Forecast, by Mode of Delivery (2021-2034)
12.2.7.4. Market Revenue and Forecast, by End-User (2021-2034)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Animal Type (2021-2034)
12.2.8.2. Market Revenue and Forecast, by Product (2021-2034)
12.2.8.3. Market Revenue and Forecast, by Mode of Delivery (2021-2034)
12.2.8.4. Market Revenue and Forecast, by End-User (2021-2034)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Animal Type (2021-2034)
12.3.2. Market Revenue and Forecast, by Product (2021-2034)
12.3.3. Market Revenue and Forecast, by Mode of Delivery (2021-2034)
12.3.4. Market Revenue and Forecast, by End-User (2021-2034)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Animal Type (2021-2034)
12.3.5.2. Market Revenue and Forecast, by Product (2021-2034)
12.3.5.3. Market Revenue and Forecast, by Mode of Delivery (2021-2034)
12.3.5.4. Market Revenue and Forecast, by End-User (2021-2034)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Animal Type (2021-2034)
12.3.6.2. Market Revenue and Forecast, by Product (2021-2034)
12.3.6.3. Market Revenue and Forecast, by Mode of Delivery (2021-2034)
12.3.6.4. Market Revenue and Forecast, by End-User (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Animal Type (2021-2034)
12.3.7.2. Market Revenue and Forecast, by Product (2021-2034)
12.3.7.3. Market Revenue and Forecast, by Mode of Delivery (2021-2034)
12.3.7.4. Market Revenue and Forecast, by End-User (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Animal Type (2021-2034)
12.3.8.2. Market Revenue and Forecast, by Product (2021-2034)
12.3.8.3. Market Revenue and Forecast, by Mode of Delivery (2021-2034)
12.3.8.4. Market Revenue and Forecast, by End-User (2021-2034)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Animal Type (2021-2034)
12.4.2. Market Revenue and Forecast, by Product (2021-2034)
12.4.3. Market Revenue and Forecast, by Mode of Delivery (2021-2034)
12.4.4. Market Revenue and Forecast, by End-User (2021-2034)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Animal Type (2021-2034)
12.4.5.2. Market Revenue and Forecast, by Product (2021-2034)
12.4.5.3. Market Revenue and Forecast, by Mode of Delivery (2021-2034)
12.4.5.4. Market Revenue and Forecast, by End-User (2021-2034)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Animal Type (2021-2034)
12.4.6.2. Market Revenue and Forecast, by Product (2021-2034)
12.4.6.3. Market Revenue and Forecast, by Mode of Delivery (2021-2034)
12.4.6.4. Market Revenue and Forecast, by End-User (2021-2034)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Animal Type (2021-2034)
12.4.7.2. Market Revenue and Forecast, by Product (2021-2034)
12.4.7.3. Market Revenue and Forecast, by Mode of Delivery (2021-2034)
12.4.7.4. Market Revenue and Forecast, by End-User (2021-2034)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Animal Type (2021-2034)
12.4.8.2. Market Revenue and Forecast, by Product (2021-2034)
12.4.8.3. Market Revenue and Forecast, by Mode of Delivery (2021-2034)
12.4.8.4. Market Revenue and Forecast, by End-User (2021-2034)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Animal Type (2021-2034)
12.5.2. Market Revenue and Forecast, by Product (2021-2034)
12.5.3. Market Revenue and Forecast, by Mode of Delivery (2021-2034)
12.5.4. Market Revenue and Forecast, by End-User (2021-2034)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Animal Type (2021-2034)
12.5.5.2. Market Revenue and Forecast, by Product (2021-2034)
12.5.5.3. Market Revenue and Forecast, by Mode of Delivery (2021-2034)
12.5.5.4. Market Revenue and Forecast, by End-User (2021-2034)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Animal Type (2021-2034)
12.5.6.2. Market Revenue and Forecast, by Product (2021-2034)
12.5.6.3. Market Revenue and Forecast, by Mode of Delivery (2021-2034)
12.5.6.4. Market Revenue and Forecast, by End-User (2021-2034)
13.1. Ceva Sante Animale
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Vetoquinol S.A.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Zoetis
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Biogenesis Bago
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Neogen Corp.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Hester Biosciences
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Phibro Animal Health
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Ceva Sante Animale
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Vetoquinol S.A.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Dechra Pharmaceuticals PLC
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample